SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (713)6/10/1999 8:36:00 PM
From: JOEBT1Read Replies (1) | Respond to of 4974
 
Peter--I would like to tap your knowledge. There are 2 companies, Aronex/ARNX and Liposome/LIPO, with a strategy analogous to SEPR. They both take existing drugs and make a liposomal version of them that is somewhat more effective with less side effects. I've already invested in LIPO and am looking at ARNX. Do you have an opinion on these companies. TIA.